Advertisement

Topics

Latest "MissionCelogos is a biotechnology company" News Stories

05:18 EST 12th December 2018 | BioPortfolio

Here are the most relevant search results for "MissionCelogos is a biotechnology company" found in our extensive news archives from over 250 global news sources.

More Information about MissionCelogos is a biotechnology company on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about MissionCelogos is a biotechnology company for you to read. Along with our medical data and news we also list MissionCelogos is a biotechnology company Clinical Trials, which are updated daily. BioPortfolio also has a large database of MissionCelogos is a biotechnology company Companies for you to search.

Showing "MissionCelogos biotechnology company" News Articles 1–25 of 23,000+

Wednesday 12th December 2018

Recordati SpA REC Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 09112018] Prices from USD $250

SummaryRecordati SpA Recordati, a subsidiary of Fimei SpA is a pharmaceutical company that researches, develops, manufactures and markets pharmaceuticals. The company offers pharmaceuticals for cardiovascular diseases, dermatology, central nervous system disorders, musculoskeletal disorders and analgesia and urology diseases. It also offers cosmetics, dietary supplements, pregnancy test products, ...


Episurf Medical AB EPIS B Medical Equipment Deals and Alliances Profile [Report Updated: 23102018] Prices from USD $250

SummaryEpisurf Medical AB Episurf Medical, formerly Diamorph Medtech AB is a medical technology company that provides patientspecific treatments of painful joint injuries. The company offers diagnosis and design of implants and surgical instruments. Its products include Episealer Femoral Twin, Episealer Trochlea Solo, Episealer Trochlea Twin, Epiguide and toolkit; and MRI protocol. Episurf Medical...

Dynatronics Corp DYNT Medical Equipment Deals and Alliances Profile [Report Updated: 06122018] Prices from USD $250

SummaryDynatronics Corp Dynatronics is a medical device company that offers rehab technology and equipment solutions. The company offers modalities, hot and cold therapy, clinical accessories, body positioning, sports medicine, orthopedics, hand therapy, strength equipment, treatment tables and rehab equipment, among others. It also offers exercise products, cardio equipment, pilates and yoga equi...


Humanwell Healthcare Group Co Ltd 600079 Medical Equipment Deals and Alliances Profile [Report Updated: 23102018] Prices from USD $250

SummaryHumanwell Healthcare Group Co Ltd Humanwell, formerly Wuhan Humanwell HiTech Industry Co Ltd is a pharmaceutical company that offers generic products. The company offers pharmaceutical, medical instrument and reproductive health care products and technologies. Its products include anesthetics, biological products, herbal medicines, CNS medicines, women's health, antiinfection drugs, medical...

DBV Technologies Highlights Data Supporting Induction of Immunotolerance Through the Skin at Inflammatory Skin Disease Summit 2018

Montrouge, France, December 12, 2018 DBV Technologies Highlights Data Supporting Induction of Immunotolerance Through the Skin at Inflammatory Skin Disease Summit 2018 First-of-its-kind study evaluated immune profile of healthy human skin in different body sites Findings support application of epicutaneous immunotherapy (EPIT) to int

Santhera Announces Financial Results for the First Nine Months of 2018

Santhera Pharmaceuticals Holding AG / Santhera Announces Financial Results for the First Nine Months of 2018 . Processed and transmitted by West Corporation. The issuer is solely responsible for the content of this announcement. Pratteln, Switzerland, December 12, 2018 - Santhera Pharmaceuticals (SIX: SANN) reports financial results for the nine months ended September 30, 2018, and...

Santhera Launches Placement of Shares through Accelerated Bookbuilding

Santhera Pharmaceuticals Holding AG / Santhera Launches Placement of Shares through Accelerated Bookbuilding . Processed and transmitted by West Corporation. The issuer is solely responsible for the content of this announcement. Pratteln, Switzerland, December 12, 2018 - Santhera Pharmaceuticals Holding Ltd (SIX: SANN) announces the launch of an ordinary capital increase of up to 5...

Acacia Pharma Group plc: Acacia Pharma announces positive clinical results for APD403 in chemotherapy induced nausea & vomiting published in Supportive Care in Cancer

ACACIA PHARMA ANNOUNCES POSITIVE CLINICAL RESULTS FOR APD403 IN CHEMOTHERAPY INDUCED NAUSEA & VOMITING PUBLISHED IN SUPPORTIVE CARE IN CANCER Cambridge, UK and Indianapolis, US - 12 December 2018: Acacia Pharma Group plc ("Acacia Pharma", the "Company") (EURONEXT: ACPH) announces that data and analyses from its positive Phase 2 clinical trial of APD403 (int...

Manipal Hospital Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 08112018] Prices from USD $250

SummaryManipal Hospital, formerly Manipal Health Systems is a healthcare service provider that offers primary, secondary and tertiary healthcare services. The hospital offers services such as robotic assisted surgery, eye care, rehabilitation, skin care, accident and emergency care, child care, dental care, home healthcare, and others. It provides services in the areas of cardiovascular, neurology...

Tuesday 11th December 2018

BIORAD Mini PROTEAN EXTRAS AND PIECES! 

$49.99End Date: Wednesday Jan-9-2019 16:20:31 PSTBuy It Now for only: $49.99Buy It Now | Add to watch list Biotech365 : BIORAD Mini PROTEAN EXTRAS AND PIECES!  BioMarketplace You want to propose your products or a Biotech Company, a Biotech Tool … Continue reading →

Eppendorf 5415C Centrifuge w/ Rotor & Power Cord

EUR 87,90 (0 Biedingen)Einddatum: maandag dec-17-2018 1:30:26 CETNu bieden | Toevoegen aan volglijst Biotech365 : Eppendorf 5415C Centrifuge w/ Rotor & Power Cord BioMarketplace You want to propose your products or a Biotech Company, a Biotech Tool or a Bioinformatic … Continue reading →

Dr. John Houston of Arvinas Named 2018 BioCT Entrepreneur of the Year

In a ceremony December 11 at the BioCT Annual Bioscience Holiday Celebration & Networking Party in New Haven, the 2018 BioCT Entrepreneur of the Year award was presented to Dr. John Houston of Arvinas, a biotechnology executive whose work has positively affected bioscience in Connecticut and beyond. Dr. Houston is President and CEO of Arvinas,...

GARDP, Eisai and Takeda announce partnership in the search for new antibiotics

(Drugs for Neglected Diseases Initiative) The Global Antibiotic Research and Development Partnership (GARDP), Eisai Co., Ltd. (TSE: 4523) ('Eisai') and Takeda Pharmaceutical Company Limited (TSE: 4502) ('Takeda') have signed an agreement for GARDP to access and screen components of Eisai and Takeda's chemical libraries.

BELLUS Health Inc BLU Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 09112018] Prices from USD $250

SummaryBELLUS Health Inc BELLUS Health is a biopharmaceutical development company, which focuses on developing drugs for rare diseases. The company's pipeline products include BLU5937 for chronic cough, Shigamab for STEC related hemolytic syndrome sHUS; KIACTA for the treatment of a second indication called sarcoidosis; AMO01 related to Fragile X syndrome and ALZ801 for the treatment of Alzheimer'...

Solid Biosciences Inc SLDB Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 23102018] Prices from USD $250

SummarySolid Biosciences Inc Solid Biosciences is a life science company focused on developing therapies for duchenne muscular dystrophy DMD. Its pipeline product candidates include SGT001, a microdystrophin gene therapy administered through adenoassociated virus AAV stabilizes dystrophin glycoprotein complex and rescue muscle function; SB001, a monoclonal antibody to reduce fibrosis and inflammat...

Anchiano Therapeutics Ltd BICL Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 09112018] Prices from USD $250

SummaryAnchiano Therapeutics Ltd Anchiano formerly BioCancell Ltd, focuses on the identification, development and commercialization of therapies for diagnosis and treatment of cancerrelated diseases such as superficial bladder carcinoma, pancreatic cancer and ovarian cancer. The company's product pipeline candidates is being evaluated for the treatment of bladder cancer, ovarian cancer and pancrea...

California Life Sciences Association (CLSA) Welcomes Proposed 5-Year Delay of Medical Device Tax

Year-end bill introduced in lame duck session recommends extending delays on certain taxes, including a 5-year moratorium on 2.3% medical device tax until December 2024 California Life Sciences Association (CLSA), the trade association representing California’s life sciences industry, welcomes the introduction of

Global Medical REIT Inc. Commences Common Stock Public Offering

Global Medical REIT Inc. (NYSE:GMRE) (the “Company”) today commenced an underwritten public offering (the “offering”) of its common stock, par value $0.001 per share, subject to market and other conditions. The Company expects to grant the underwriters a 30-day option to purchase an additional 15% of the shares of common stock being offered in the ...

Aeglea BioTherapeutics Announces Design of Pivotal Phase 3 PEACE Trial Evaluating Pegzilarginase in Arginase 1 Deficiency

Single, Global Pivotal Trial to Support Registration; Primary Endpoint of Arginine Reduction Expected to Initiate in Q2 2019; Topline Data Anticipated in Q1 2021 Company to Host Conference Call Today at 5:00 p.m. ET AUSTIN, Texas, Dec. 11, 2018 (GLOBE … Continue reading →

Intersect ENT to Present at the 37th Annual J.P. Morgan Healthcare Conference

Intersect ENT, Inc. (Nasdaq: XENT), today announced that management will participate in the 37th Annual J.P. Morgan Healthcare Conference on Tuesday, January 8, 2019 at the Westin St. Francis Hotel in San Francisco, and will present at 4:30 p.m. PT. A replay of the session will be available via the investors section of the company’s websi...

Frelii Releases Information Regarding The Licensing Of Its Technology For The Canadian Medical Cannabis Industry

Frelii provides a shareholder update on the company’s intent to partner with NewPath Healthcare Solutions, Inc., a company incorporated under the laws of Ontario, Canada, in an effort to make medical cannabis use safer for the patient, inspire confidence in the prescribing physician, and create trust in the industry as a whole. LEHI, Utah (PRWEB) December 11, 2018 Frelii’s management team has...

Axonics® Announces Third Quarter 2018 Financial Results and Operational Update

Axonics Modulation Technologies, Inc. (NASDAQ: AXNX) a medical technology company focused on the development and commercialization of novel implantable Sacral Neuromodulation (“SNM”) devices for the treatment of urinary and bowel dysfunction, reported today financial results for the quarter ended September 30, 2018 and provided an u...

Arrowhead Pharmaceuticals Reports Fiscal 2018 Year End Results

Conference Call and Webcast Today at 4:30 p.m. EST Arrowhead Pharmaceuticals Inc. (NASDAQ: ARWR) today announced financial results for its fiscal 2018 fourth quarter and year ended September 30, 2018. The company is hosting a conference call at 4:30 p.m. EST to discuss results. Conference Call and Webcast Details Investors may ...

Tenax Therapeutics Announces Closing of $10 Million Underwritten Offering

Tenax Therapeutics, Inc. (Nasdaq: TENX) (“Tenax” or the “Company”), a specialty pharmaceutical company focused on identifying, developing and commercializing products for the critical care market, today announced the closing of an underwritten offering for gross proceeds of approximately $10 million, prior to deducting underwriting discounts and co...

Mobidiag Ltd Medical Equipment Deals and Alliances Profile [Report Updated: 06122018] Prices from USD $250

SummaryMobidiag Ltd Mobidiag is a biotechnology company that develops and markets products for molecular diagnosis of infectious diseases and test kits. The company's products include Novodiag, Amplidiag, and Proveit. Its Amplidiag is a diagnostic test for highvolume screening of gastrointestinal pathogens and antibiotic resistances. Mobidiag's Proveit products include proveit sepsis, proveit bone...


Advertisement
Quick Search
Advertisement
Advertisement

 

News Quicklinks